Bayer CropScience Limited (BOM: 506285)
6,483.75
0.00 (0.00%)
At close: Sep 11, 2024
Bayer CropScience Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Operating Revenue | 49,948 | 51,032 | 51,397 | 47,344 | 42,613 | 36,094 | Upgrade
|
Revenue | 49,948 | 51,032 | 51,397 | 47,344 | 42,613 | 36,094 | Upgrade
|
Revenue Growth (YoY) | -4.17% | -0.71% | 8.56% | 11.10% | 18.06% | 13.67% | Upgrade
|
Cost of Revenue | 29,128 | 29,256 | 28,305 | 26,771 | 24,619 | 19,265 | Upgrade
|
Gross Profit | 20,820 | 21,776 | 23,092 | 20,573 | 17,994 | 16,829 | Upgrade
|
Selling, General & Admin | 6,965 | 6,902 | 8,616 | 7,836 | 5,726 | 5,729 | Upgrade
|
Other Operating Expenses | 5,204 | 5,117 | 5,211 | 4,589 | 4,148 | 3,825 | Upgrade
|
Operating Expenses | 12,811 | 12,759 | 14,622 | 13,070 | 10,609 | 10,207 | Upgrade
|
Operating Income | 8,009 | 9,017 | 8,470 | 7,503 | 7,385 | 6,622 | Upgrade
|
Interest Expense | -159 | -196 | -223 | -118 | -110 | -126 | Upgrade
|
Interest & Investment Income | 484 | 484 | 340 | 245 | 314 | 353 | Upgrade
|
Currency Exchange Gain (Loss) | -2 | -2 | -22 | -2 | -15 | -11 | Upgrade
|
Other Non Operating Income (Expenses) | 246 | 178 | 159 | 184 | 157 | 221 | Upgrade
|
EBT Excluding Unusual Items | 8,578 | 9,481 | 8,724 | 7,812 | 7,731 | 7,059 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | 51 | -1,302 | Upgrade
|
Gain (Loss) on Sale of Investments | 148 | 148 | 135 | 94 | 103 | 7 | Upgrade
|
Gain (Loss) on Sale of Assets | -24 | -24 | 1,043 | 579 | 64 | 79 | Upgrade
|
Asset Writedown | -191 | -191 | -1 | -17 | -4 | -12 | Upgrade
|
Pretax Income | 8,511 | 9,414 | 9,901 | 8,468 | 7,945 | 5,831 | Upgrade
|
Income Tax Expense | 1,849 | 2,009 | 2,319 | 2,015 | 3,014 | 1,086 | Upgrade
|
Net Income | 6,662 | 7,405 | 7,582 | 6,453 | 4,931 | 4,745 | Upgrade
|
Net Income to Common | 6,662 | 7,405 | 7,582 | 6,453 | 4,931 | 4,745 | Upgrade
|
Net Income Growth | -15.04% | -2.33% | 17.50% | 30.87% | 3.92% | 40.76% | Upgrade
|
Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
Shares Change (YoY) | -0.00% | - | - | - | - | 4.60% | Upgrade
|
EPS (Basic) | 148.24 | 164.77 | 168.71 | 143.58 | 109.72 | 105.58 | Upgrade
|
EPS (Diluted) | 148.24 | 164.77 | 168.71 | 143.58 | 109.72 | 105.58 | Upgrade
|
EPS Growth | -15.03% | -2.33% | 17.50% | 30.87% | 3.92% | 34.57% | Upgrade
|
Free Cash Flow | - | 9,059 | 5,320 | 1,601 | 6,447 | 6,246 | Upgrade
|
Free Cash Flow Per Share | - | 201.57 | 118.37 | 35.62 | 143.45 | 138.98 | Upgrade
|
Dividend Per Share | - | 140.000 | 130.000 | 25.000 | 115.000 | 25.000 | Upgrade
|
Dividend Growth | - | 7.69% | 420.00% | -78.26% | 360.00% | 38.89% | Upgrade
|
Gross Margin | 41.68% | 42.67% | 44.93% | 43.45% | 42.23% | 46.63% | Upgrade
|
Operating Margin | 16.03% | 17.67% | 16.48% | 15.85% | 17.33% | 18.35% | Upgrade
|
Profit Margin | 13.34% | 14.51% | 14.75% | 13.63% | 11.57% | 13.15% | Upgrade
|
Free Cash Flow Margin | - | 17.75% | 10.35% | 3.38% | 15.13% | 17.30% | Upgrade
|
EBITDA | 8,395 | 9,404 | 8,861 | 7,901 | 7,799 | 7,047 | Upgrade
|
EBITDA Margin | 16.81% | 18.43% | 17.24% | 16.69% | 18.30% | 19.52% | Upgrade
|
D&A For EBITDA | 386 | 387 | 391 | 398 | 414 | 425 | Upgrade
|
EBIT | 8,009 | 9,017 | 8,470 | 7,503 | 7,385 | 6,622 | Upgrade
|
EBIT Margin | 16.03% | 17.67% | 16.48% | 15.85% | 17.33% | 18.35% | Upgrade
|
Effective Tax Rate | 21.72% | 21.34% | 23.42% | 23.80% | 37.94% | 18.62% | Upgrade
|
Revenue as Reported | 50,826 | 51,842 | 52,036 | 47,890 | 43,251 | 36,754 | Upgrade
|
Advertising Expenses | - | 2,412 | 3,153 | 3,080 | 1,991 | 1,982 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.